144 related articles for article (PubMed ID: 33621788)
1. Elevated levels of oxidized nucleosides in individuals with the JAK2V617F mutation from a general population study.
Sørensen AL; Hasselbalch HC; Bjørn ME; Nielsen CH; Cordua S; Skov V; Kjær L; Poulsen HE; Ellervik C
Redox Biol; 2021 May; 41():101895. PubMed ID: 33621788
[TBL] [Abstract][Full Text] [Related]
2. Hypothyroid women have persistently higher oxidative stress compared to healthy controls.
Riis KR; Larsen CB; Medici BR; Jensen CZ; Winther KH; Larsen EL; Ellervik C; la Cour JL; Hegedüs L; Brix TH; Poulsen HE; Knop FK; Nygaard B; Bonnema SJ
Eur Thyroid J; 2023 Dec; 12(6):. PubMed ID: 37855410
[TBL] [Abstract][Full Text] [Related]
3. Frequencies, Laboratory Features, and Granulocyte Activation in Chinese Patients with CALR-Mutated Myeloproliferative Neoplasms.
Guo H; Chen X; Tian R; Chang J; Li J; Tan Y; Xu Z; Ren F; Zhao J; Pan J; Zhang N; Wang X; He J; Yang W; Wang H
PLoS One; 2015; 10(9):e0138250. PubMed ID: 26375990
[TBL] [Abstract][Full Text] [Related]
4. Coexisting JAK2V617F and CALR Exon 9 Mutations in Myeloproliferative Neoplasms - Do They Designate a New Subtype?
Ahmed RZ; Rashid M; Ahmed N; Nadeem M; Shamsi TS
Asian Pac J Cancer Prev; 2016; 17(3):923-6. PubMed ID: 27039813
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of JAK2、CALR and MPL gene mutations in 1 648 Philadelphia chromosome negative myeloproliferative neoplasms patients from a single center].
Li MY; Chao HY; Sun AN; Qiu HY; Jin ZM; Tang XW; Han Y; Fu CC; Chen SN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):295-300. PubMed ID: 28468090
[No Abstract] [Full Text] [Related]
6. JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation.
Czech J; Cordua S; Weinbergerova B; Baumeister J; Crepcia A; Han L; Maié T; Costa IG; Denecke B; Maurer A; Schubert C; Feldberg K; Gezer D; Brümmendorf TH; Müller-Newen G; Mayer J; Racil Z; Kubesova B; Knudsen T; Sørensen AL; Holmström M; Kjær L; Skov V; Larsen TS; Hasselbalch HC; Chatain N; Koschmieder S
Leukemia; 2019 Apr; 33(4):995-1010. PubMed ID: 30470838
[TBL] [Abstract][Full Text] [Related]
7. CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms.
Ojeda MJ; Bragós IM; Calvo KL; Williams GM; Carbonell MM; Pratti AF
Hematology; 2018 May; 23(4):208-211. PubMed ID: 28990497
[TBL] [Abstract][Full Text] [Related]
8. CALR, JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable.
Kim SY; Im K; Park SN; Kwon J; Kim JA; Lee DS
Am J Clin Pathol; 2015 May; 143(5):635-44. PubMed ID: 25873496
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Hyperthyroidism Reduces Systemic Oxidative Stress, as Measured by Markers of RNA and DNA Damage.
Larsen CB; Riis KR; Winther KH; Larsen EL; Ellervik C; Hegedüs L; Brix TH; Poulsen HE; Bonnema SJ
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2512-e2520. PubMed ID: 33901280
[TBL] [Abstract][Full Text] [Related]
10. An
Jorgensen A; Thygesen MB; Kristiansen U; Poulsen HE
Scand J Clin Lab Invest; 2021 Nov; 81(7):540-545. PubMed ID: 34511003
[TBL] [Abstract][Full Text] [Related]
11. Classification and Temporal Variability in Urinary 8-oxodG and 8-oxoGuo: Analysis by UHPLC-MS/MS.
Li Z; Yao Y; Zhang Y; Zhang Y; Shao Y; Tang C; Qu W; Zhou Y
Sci Rep; 2019 Jun; 9(1):8187. PubMed ID: 31160621
[TBL] [Abstract][Full Text] [Related]
12. Oxidative Stress-Induced Damage to RNA and DNA and Mortality in Individuals with Psychiatric Illness.
Jorgensen A; Brandslund I; Ellervik C; Henriksen T; Weimann A; Andersen MP; Torp-Pedersen C; Andersen PK; Jorgensen MB; Poulsen HE
JAMA Psychiatry; 2024 May; 81(5):516-520. PubMed ID: 38446448
[TBL] [Abstract][Full Text] [Related]
13. Characterization of CD34+ hematopoietic progenitor cells in JAK2V617F and CALR-mutated myeloproliferative neoplasms.
Angona A; Alvarez-Larrán A; Bellosillo B; Longarón R; Camacho L; Fernández-Rodríguez MC; Pairet S; Besses C
Leuk Res; 2016 Sep; 48():11-5. PubMed ID: 27427771
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Risk for Specific Somatic Myeloproliferative Neoplastic Mutations in Patients with Stroke.
Chen CC; Hsu CC; Huang CE; Chen YY; Lung J; Ho HY; Li CP; Lee JD
Curr Neurovasc Res; 2017; 14(3):222-231. PubMed ID: 28625126
[TBL] [Abstract][Full Text] [Related]
15. The effects of mutational profiles on phenotypic presentation of myeloproliferative neoplasm subtypes in Bosnia: 18 year follow-up.
Kurtovic-Kozaric A; Islamagic E; Komic H; Bilalovic N; Eminovic I; Burekovic A; Uzunovic A; Kurtovic S
Bosn J Basic Med Sci; 2020 May; 20(2):236-247. PubMed ID: 31668145
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory.
Agarwal R; Blombery P; McBean M; Jones K; Fellowes A; Doig K; Forsyth C; Westerman DA
Ann Hematol; 2017 May; 96(5):725-732. PubMed ID: 28161773
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between Calreticulin Gene Mutation and JAK2/MPL Negative Myeloproliferative Neoplasms].
Dong L; Shen XL; Wei W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1532-4. PubMed ID: 26524072
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and phenotypes of
Cordua S; Kjaer L; Skov V; Pallisgaard N; Hasselbalch HC; Ellervik C
Blood; 2019 Aug; 134(5):469-479. PubMed ID: 31217187
[TBL] [Abstract][Full Text] [Related]
19. Oxidatively generated modifications to nucleic acids in vivo: Measurement in urine and plasma.
Poulsen HE; Weimann A; Henriksen T; Kjær LK; Larsen EL; Carlsson ER; Christensen CK; Brandslund I; Fenger M
Free Radic Biol Med; 2019 Dec; 145():336-341. PubMed ID: 31586654
[TBL] [Abstract][Full Text] [Related]
20. Differential time responses in inflammatory and oxidative stress markers after a marathon: An observational study.
Larsen EL; Poulsen HE; Michaelsen C; Kjær LK; Lyngbæk M; Andersen ES; Petersen-Bønding C; Lemoine C; Gillum M; Jørgensen NR; Ploug T; Vilsbøll T; Knop FK; Karstoft K
J Sports Sci; 2020 Sep; 38(18):2080-2091. PubMed ID: 32530734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
